Emalex Biosciences announced positive topline data from its Phase 3 registrational study of ecopipam, a novel dopamine-1 receptor antagonist, in subjects with Tourette syndrome. The company will meet ...

Acute respiratory infections (ARIs) are a common cause of illness in children younger than 16 years and adults older than 65 ...

Intra-Cellular Therapies’ CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar depression. With its differentiated safety profile ...

Protagonist Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update $165.0 million icotrokinra (formerly JNJ-2113) milestone earned in Q4 2024, received in January ...

These new data further validate TP-317’s unique mechanism of action and its potential as an oral, first-in-class therapy for IBD,” said Gary Mathias, CEO of Thetis Pharmaceuticals. “The preclinical ...

Striatal dopamine (DA) release regulates reward-related learning and behavioural activation and is believed to consist of a short-lived phasic and continuous tonic component. Here, we build a ...

Oli Welsh is senior editor, U.K., providing news, analysis, and criticism of film, TV, and games. He has been covering the business & culture of video games for two decades. While it may seem an ...

Commercials run by the telehealth company Hims & Hers have been placed under the microscope as lawmakers are calling out ...

"Adherence improves when treatment integrates easily into patients’ lives," explains Adam McBride, Eden’s CEO. Eden’s digital ...

Exercise isn't a cure for depression, but it can encourage the release of hormones that help lift your mood. It can also boost your self-confidence and help you sleep better. (Photo Credit: Moment ...

Copyright 2025 The Associated Press. All Rights Reserved. Elon Musk is rapidly consolidating control over large swaths of the federal government with President Donald ...